Andrew Cooper, DO
Physical Medicine & Rehabilitation · Idaho Falls, IDNPI 1093154023
Payments from drug & device makers
What this record shows
12 manufacturers reported payments, led by Boston Scientific at 53.7% of the total. Reporting peaked in 2024 at $2,047 and has fallen 92.4% since, to $156 in 2025.
Across 88 payments — averaging $37.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$2K
- AbbVie$1K
- Nevro Corp.$164
- Teva Pharmaceuticals USA, Inc.$108
- Stimwave Technologies Incorporated$86
- Smith+Nephew$53
- plus $102 from 6 others
What the payments were for
- Travel & lodging$1,40942%
- Food & beverage$1,92058%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 14 | $1,789 |
| AbbVie(2 entities) | 52 | $1,028 |
| Nevro Corp. | 6 | $164 |
| Teva Pharmaceuticals USA, Inc. | 7 | $108 |
| Stimwave Technologies Incorporated | 2 | $86 |
| Smith+Nephew | 1 | $53 |
| Ipsen Biopharmaceuticals, Inc | 1 | $23 |
| Ferring Pharmaceuticals Inc. | 1 | $19 |
| Piramal Critical Care | 1 | $17 |
| Bioventus LLC | 1 | $15 |
| Nalu Medical, Inc. | 1 | $15 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $12 |
How this compares
$3,330 in reported general payments places this provider in the 85th percentile of 38 physical medicine & rehabilitation providers in Idaho.
See all physical medicine & rehabilitation providers in Idaho →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 21 | $1,393 |
| Gabapentin | 91 | $780 |
| Tizanidine Hcl | 43 | $231 |
| Meloxicam | 34 | $76 |
| Naproxen | 11 | $45 |
| Tramadol Hcl | 19 | $44 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in Idaho Falls
- Troy BushmanIdaho Falls$1K
- Bryan BakerIdaho Falls$1K
- Sarah VlachIdaho Falls$510
- Tyler HedinIdaho Falls$464
- David SimonIdaho Falls$74
- Neilly BuckalewCoeur D Alene$33K
- Robert FriedmanBoise$18K
- Donald AdamsMeridian$6K
- James WhitakerBoise$4K
- Christian GussnerMeridian$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.